Progenity, Inc. Appoints Adi Mohanty as Chief Executive Officer
November 09, 2021 at 06:30 am EST
Progenity, Inc. announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Adi Mohanty is an experienced biotech business leader with a track record of several successful product development and approvals followed by rapid commercialization. Previously, he served as CEO of BioTime. Adi formerly served as vice president at Transkaryotic Therapies, which was acquired by Shire PLC.